Journal
DERMATOLOGY
Volume 218, Issue 1, Pages 69-70Publisher
KARGER
DOI: 10.1159/000161122
Keywords
Anti-CTLA4 monoclonal antibody; Ipilimumab; Melanoma; Sarcoidosis